Literature DB >> 624852

Hepatitis B virus infections among Danish dentists.

J Aldershvile, A Brock, O Dietrichson, F Hardt, E Juhl, S Madsbad, L Mathiesen, P Matzen, J O Nielsen, P Schlichting, S Sørensen, U Tage-Jensen.   

Abstract

Since type B hepatitis is generally regarded as an occupational risk for dentists, the participants at the 1976 annual meeting of the Danish Dental Association were examined for hepatitis B surface antigen (HBsAg) and antibody to HBsAg (anti-HBs). A total of 1,338 dentists (89% of the dentists at the meeting and 29% of all Danish dentists) were included in the study by completion of a questionnaire and by radioimmunoassay of a blood sample for HGsAg and anti-HBs. None of the dentists was HBsAg-positive, but 110 (8.2%) had anti-HBs. An increasing frequency of anti-HBs was found with increasing age, but the figures were similar to the findings in a control population. Evidence is presented that hepatitis found before admittance to or during the time at dental school was predominantly not of type B. In contrast, type B hepatitis predominated during the professional activity of the dentists. On the basis of the serological findings in 29% of all Danish dentists, it is concluded that dentists cannot be regarded as a high-risk group for hepatitis B.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 624852     DOI: 10.1093/infdis/137.1.63

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  3 in total

1.  Hepatitis B virus infection in patients with rheumatic diseases.

Authors:  H Permin; J Aldershvile; J O Nielsen
Journal:  Ann Rheum Dis       Date:  1982-10       Impact factor: 19.103

2.  Viral hepatitis in Danish health care personnel, 1974-78.

Authors:  P Skinhøj; M Søeby
Journal:  J Clin Pathol       Date:  1981-04       Impact factor: 3.411

3.  Prevalence of hepatitis B virus infection among alcoholic patients with liver disease.

Authors:  M Orholm; J Aldershvile; U Tage-Jensen; P Schlichting; J O Nielsen; F Hardt; P Christoffersen
Journal:  J Clin Pathol       Date:  1981-12       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.